News
The Common European Submission Platform
2012-12-05 The Heads of Medicines Agencies (HMA) is currently carrying out an ‘extended proof of concept’ for the Common European Submission Platform (CESP) project aimed at… Read More »
Suggestions for increasing generics use in Abu Dhabi
2012-12-03 This concluding article in a series of three suggests ways of improving the use of generics in Abu Dhabi. Potential benefits from a changed situationLimited… Read More »
Australian patients ‘very positive’ about generics
2012-11-30 A new survey shows 75% of Australians believe that the government should offer a price discount to consumers who choose generics. Generics are popular with… Read More »
Overview of research on safety and immunogenicity of biosimilars in 2012
2012-11-29 Period: January to August 2012 Biosimilars or ‘biosimilar medicinal products’ are medicinal products that are similar (but not identical) in terms of quality, safety and… Read More »
EMA publishes revised biosimilar Q&A document for patients
2012-11-28 On 27 September 2012 EMA published its revised Questions and Answers (Q&A) document on biosimilar medicines aimed at patients and the general public. The revised… Read More »
EMA to accept biosimilar reference medicines from outside EEA
2012-11-27 EMA announced on 28 September 2012 that it has adapted its guidance in order to make it easier for new biosimilar products to be approved… Read More »
Generics substitution: Ireland’s plan for reference pricing
2012-11-26 A bill that will be debated this autumn seeks to introduce generics substitution and reference pricing for medicines and medical and surgical appliances in Ireland.… Read More »
ABPI concerned about medicines misconceptions
2012-11-23 The Association of the British Pharmaceutical Industry (ABPI) represents innovative research-based biopharmaceutical companies in the UK. In a new survey commissioned by the association issues… Read More »
Italian Medicines Agency publishes concept paper on biosimilars
2012-11-21 The Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) announced on 1 August 2012 the release of a concept paper on biosimilars. The purpose of the… Read More »
Poor quality pharma ingredients abound in China
2012-11-19 Lack of regulatory enforcement in China is allowing poor quality pharmaceutical ingredients to be sold to drug manufacturers with potentially dangerous or even fatal consequences… Read More »
